Home›People›John Childs
JC

John Childs

Director at Veradermics.

DirectorPublic company
Updated Nov 9, 2026·Latest SEC filing Aug 14, 2026·Suggest an edit

About John Childs

John Childs is a director at Veradermics.

John Childs reports to the SEC as a director, officer or major shareholder of 5 public companies, including Biohaven (BHVN), Biohaven Pharmaceutical Holding Co (BHVN) and Mattress Firm Holding (MFRM).

John Childs first appears on SEC filings in 2010.

Experience

This experience comes from SEC filings. The years are when the filings name John Childs in the role, so the role may have started earlier or lasted longer.

Veradermics, Inc
Director
2021 – 2026 · Public company (MANE)
Biohaven Ltd.
Director
2022 – 2026 · Public company (BHVN)
Biohaven Pharmaceutical Holding Co Ltd.
Director and 10% owner
2017 – 2022 · Public company (BHVN)
Mattress Firm Holding Corp.
Director and 10% owner
2011 – 2016 · Public company (MFRM)
JWC Acquisition Corp.
Chairman & CEO
2010 – 2012 · Public company (JWCA)

Key Colleagues at Startups

The people John Childs works with at each company, as listed on that company's latest Form D.

Veradermics, Inc · Form D, May 15, 2026
PE
DF
David Friedman
Director
JK
VC
MG
Michael Greco
Executive officer
RW
Reid Waldman
Chief Executive Officer and director
KP
MN
Mark Neumann
Executive officer
DC
Dominic Carrano
Executive officer
TD
Tim Durso
Executive officer

Sources

  1. SECVeradermics, Inc Form D, filed May 15, 2026
  2. SECForms 3, 4 and 5 filed by John Childs (SEC filer 1027035)